Publications by authors named "Lyly Le"

Claim this Profile
O
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Daniel J Khalaf, Matti Annala, Sinja Taavitsainen, Daygen L Finch, Conrad Oja, Lyly Le, Martin E Gleave, Alexander W Wyatt

Lancet Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome.
Carol Cremin, Sarah Howard, Lyly Le, Aly Karsan, David F Schaeffer

Hered Cancer Clin Pract· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
Daniel Joseph Khalaf, Claudia M Avilés, Arun A Azad, Katherine Sunderland, Tilman Todenhöfer, Lyly Le

Can Urol Assoc J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209.
Bernhard Josef Eigl, Kim Chi, Dongsheng Tu, Sebastien J Hotte, Eric Winquist, Kylea Potvin, Lyly Le, Ashley Theis, Lesley Seymour

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials.
Chris Coppin, Christian Kollmannsberger, Lyly Le, Franz Porzsolt, Timothy J Wilt

BJU Int· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies.
Sébastien J Hotte, Hal W Hirte, Eric X Chen, Lillian L Siu, Lyly H Le, Martha MacLean

Clin Cancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours.
Lyly H Lê, Malcolm J Moore, Lillian L Siu, Amit M Oza, Martha MacLean, Lesley Seymour

Cancer Chemother Pharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor expression in anal canal carcinoma.
Lyly H Lê, Runjan Chetty, Malcolm J Moore

Am J Clin Pathol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions.
Lyly Le, Kim Chi, Scott Tyldesley, Stephane Flibotte, Deborah L Diamond

Clin Chem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days.
Lyly H Lê, Charles Erlichman, Linda Pillon, Jake J Thiessen, Andrew Day

Invest New Drugs· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis